I agree that this site is using cookies. You can find further informations here.
X
Składowski, K.
101  results:
Search for persons X
?
1

Analysis of efficacy and safety of vismodegib therapy in pa..:

Słowińska, M. ; Dudzisz‐Śledź, M. ; Sobczuk, P....
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  8 - p. 1219-1228 , 2022
Link: https://doi.org/10.1111/..
 
?
2

Does Accelerated Fractionation Improve Radiation Results in..:

Wygoda, A. ; Mrochem-Kwarciak, J.J. ; Rutkowski, T....
International Journal of Radiation Oncology*Biology*Physics.  106 (2020)  5 - p. 1145 , 2020
Link: https://doi.org/10.1016/..
 
?
3

Hyperfractionated Radiotherapy Alone or in Sequential Combi..:

Wygoda, A. ; Rutkowski, T. ; Mrochem-Kwarciak, J.J....
International Journal of Radiation Oncology*Biology*Physics.  106 (2020)  5 - p. 1154 , 2020
Link: https://doi.org/10.1016/..
 
?
4

Concurrent ChemoRadiation (CCR) is better than Accelerated ..:

Księżniak-Baran, D. ; Stankiewicz, M. ; Wygoda, A....
International Journal of Radiation Oncology*Biology*Physics.  106 (2020)  5 - p. 1128 , 2020
Link: https://doi.org/10.1016/..
 
?
5

NMR-based metabolomics in real-time monitoring of treatment..:

Boguszewicz, Ł. ; Bieleń, A. ; Mrochem-Kwarciak, J....
Metabolomics.  15 (2019)  8 - p. , 2019
Link: https://doi.org/10.1007/..
 
?
6

PO-0721 Prognostic Value of Inflammatory Markers in Patient..:

Mrochem-Kwarciak, J. ; Rutkowski, T. ; Wygoda, A...
Radiotherapy and Oncology.  133 (2019)  - p. S370 , 2019
Link: https://doi.org/10.1016/..
 
?
7

Prognostic value of erythropoietin (EPO), soluble erythropo..:

Mrochem-Kwaciak, J. ; Wygoda, A. ; Deja, R....
Clinica Chimica Acta.  493 (2019)  - p. S126 , 2019
Link: https://doi.org/10.1016/..
 
?
8

Prognostic Value of Reticulocyte, Immature Reticulocyte, an..:

Mrochem-Kwarciak, J.J. ; Rutkowski, T. ; Wygoda, A....
International Journal of Radiation Oncology*Biology*Physics.  100 (2018)  5 - p. 1364 , 2018
Link: https://doi.org/10.1016/..
 
?
9

Endogenic Erythropoietin Levels are Fluctuated and Conseque..:

Leś, D. ; Mrochem-Kwarciak, J.J. ; Wygoda, A...
International Journal of Radiation Oncology*Biology*Physics.  100 (2018)  5 - p. 1349 , 2018
Link: https://doi.org/10.1016/..
 
?
10

PD-027: cfHPV DNA as a marker of treatment results in patie..:

Rutkowski, T. ; Mazurek, A. ; Snietura, M....
Radiotherapy and Oncology.  122 (2017)  - p. 16-17 , 2017
Link: https://doi.org/10.1016/..
 
?
11

PO-101: Osteopontin (OPN) as an instant, predictive marker ..:

Mrochem-Kwarciak, J. ; Rutkowski, T. ; Wygoda, A....
Radiotherapy and Oncology.  122 (2017)  - p. 48-49 , 2017
Link: https://doi.org/10.1016/..
 
?
12

EP-1083: HPV as an etiological and prognostic factor for th..:

Brewczyński, A. ; Rutkowski, T. ; Mazurek, A....
Radiotherapy and Oncology.  123 (2017)  - p. S595-S596 , 2017
Link: https://doi.org/10.1016/..
 
?
13

PO-123: Hypothyroidism after radiotherapy of head and neck ..:

Dworzecka, U. ; Wygoda, A. ; Rutkowski, T...
Radiotherapy and Oncology.  122 (2017)  - p. 59 , 2017
Link: https://doi.org/10.1016/..
 
?
14

Circulating Cell-Free Human Papillomavirus DNA as a Marker ..:

Rutkowski, T. ; Mazurek, A. ; Snietura, M....
International Journal of Radiation Oncology*Biology*Physics.  96 (2016)  2 - p. S41 , 2016
Link: https://doi.org/10.1016/..
 
?
15

CYFRA 21-1 as an Instant Prognostic Marker of Tumor Respons..:

Mrochem-Kwarciak, J.J. ; Rutkowski, T. ; Wygoda, A....
International Journal of Radiation Oncology*Biology*Physics.  94 (2016)  4 - p. 879 , 2016
Link: https://doi.org/10.1016/..
 
1-15